Correction: PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia–reperfusion injury (Stem Cell Research & Therapy, (2022), 13, 1, (167), 10.1186/s13287-022-02840-0)

Charlotte Sarre, Rafael Contreras-Lopez, Nitirut Nernpermpisooth, Christian Barrere, Sarah Bahraoui, Claudia Terraza, Gautier Tejedor, Anne Vincent, Patricia Luz-Crawford, Kantapich Kongpol, Sarawut Kumphune, Christophe Piot, Joel Nargeot, Christian Jorgensen, Farida Djouad*, Stéphanie Barrere-Lemaire*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

1 Scopus citations

Abstract

The original article contained errors in the attribution of affiliations which have since been corrected.

Original languageEnglish
Article number338
Pages (from-to)338
JournalStem Cell Research and Therapy
Volume13
Issue number1
DOIs
StatePublished - Dec 2022

Bibliographical note

Publisher Copyright:
© 2022, The Author(s).

Fingerprint

Dive into the research topics of 'Correction: PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia–reperfusion injury (Stem Cell Research & Therapy, (2022), 13, 1, (167), 10.1186/s13287-022-02840-0)'. Together they form a unique fingerprint.

Cite this